Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

atoplab.com
 

Enter Stock Symbol:  

Ironwood Pharmaceuticals Inc. (IRWD)

16.71 -0.44 (-2.57%)

10-19 16:00

Open:

17.03

Pre. Close:

17.15

High:

17.51

Low:

16.55

Volume:

1,214,069

Market Cap:

2559M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

17.529 - 17.672

17.672 - 17.768

Low:

16.263 - 16.416

16.416 - 16.518

Close:

16.51 - 16.747

16.747 - 16.906

Technical analysis  (as of: 2018-10-19 4:36:18 PM)

Overall:

      

Stoxline posted a SELL today, downgraded from higher rating. This stock seems to be ready for a new bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 21.17     One year: 22.61

Support:

Support1: 16.12    Support2: 13.41

Resistance:

Resistance1: 18.12    Resistance2: 19.36

Pivot:

17.50

Moving Averages:

MA(5): 17.04     MA(20): 17.66

MA(100): 18.55     MA(250): 16.87

MACD:

MACD(12,26): -0.34     Signal(12,26,9): -0.28

%K %D:

%K(14,3): 30.25     %D(3): 33.40

RSI:

RSI(14): 42.13

52-Week:

High: 21.2  Low: 12.89  Change(%): 15.1

Average Vol(K):

3-Month: 89205  10-Days 115976

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
IRWD has closed above bottom band by 25.7%. Bollinger Bands are 52.1% wider than normal. The large width of the bands suggest high volatility as compared to IRWD's normal range. The bands have been in this wide range for 5 bars. This is a sign that the current trend might continue.

Headline News

2018-10-10T07:21:41-04:00
Novartis' crizanlizumab showed effect on vaso-occlusive crises in mid-stage sickle cell study

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Drug Manufacturers - Specialty Generic

Shares Out. (M)

153.16

Shares Float (M)

145.93

% Held by Insiders

% Held by Institutions

Shares Short (K)

13938

Shares Short Prior Month (K)

Stock Financials

EPS

-0.870

EPS Est. Current Year

-1.110

EPS Est. Next Year

-0.580

EPS Est. Next Quarter

-0.240

Forward EPS

-0.050

Book Value (p.s.)

279.570

PEG Ratio

-0.35

Profit Margin

-33.28

Operating Margin

-31.70

Return on Assets (ttm)

-16.8

Return on Equity (ttm)

578.6

Qtrly Rev. Growth

24.6

Gross Profit (p.s.)

1.082

Sales Per Share

EBITDA (p.s.)

0.044

Qtrly Earnings Growth

Operating Cash Flow (M)

-92.84

Levered Free Cash Flow (M)

-74.81

Valuation

P/E

-19.21

P/E Growth Ratio

-0.03

P/BV

0.06

P/S

1057135296.00

P/CF

-27.57

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.